Thank you. It's important to get some understanding of the background of the system. It originated in the last century. By the time the iPhone was invented, it was a troublesome teenager. It was written in a language that very few people in the world understood. Microsoft support was essentially removed, and the software could not be configured to user requirements, because the technical understanding wasn't there. We replatformed the software onto, essentially, hardware that meant that it was more robust, and then we left it alone. And then we worked to extract the cancer record to enable a summary of every cancer patient to go into the Welsh clinical portal, the document repository element. That, actually, revolutionised what I could see as a clinician.
Just to highlight, if you don't mind, I diagnose bladder cancer patients. They then go to Velindre, so they cross a border, for neoadjuvant chemotherapy—that's chemotherapy before they have their major surgery. They then come down the M4 past me to Morriston Hospital, where they have their bladder out, and then they come back to me for follow-up care. So, that individual is going to have gone across a number of health board boundaries, all using different systems. Because we were able to extract that record, for the first time in my career, I was actually able to see what was happening to those patients. That gives patients massive confidence. It also gives clinicians massive confidence, because you're up to date with what's happening to the patient.
Subsequent to that, we worked with the users of CaNISC, and to put it in context, there are about 2,000 users across Wales. It's primarily for non-surgical oncology pathways. It's used to process data, it contributes to our national audits, to allow us to understand where we are, how we benchmark across other disease-specific areas. The Welsh clinical portal has 35,000 users, it's visible in an ambulance hub, it's visible in your accident and emergency departments, it's visible across primary care, it's visible across all our hospitals. So, when those cancer patients now present into those acute environments, their record is visible.
Since then, we've worked closely with the leadership of Velindre to understand what the functionality requirements are, going forward, for the staff, and I'm very pleased to say this weekend just gone, we've done our first dry run for data migration of the pathways. The worry for patients who move across boundaries is that they can get lost, and it's a big concern for clinicians, as you can imagine. Some people say it's like trying to change the engine of a plane in the air; you've got work to do, you've got to try and replatform it and you've got to make sure everyone moves safely across. We anticipate that, in November, we will be able to decommission a large element of the cancer work that is done in CaNISC as part of what we call phase 1, and we'll then move on to look at how we manage the palliative care journey and the screening services.